Clinical trials
Lymphoma, T-Cell, Peripheral trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 7 |
| Acrotech Biopharma Inc. | 2 |
| Associazione Angela Serra per la ricerca sul cancro | 2 |
| AstraZeneca | 2 |
| Fondazione Italiana Linfomi - ETS | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| SecuraBio | 2 |
| Spectrum Pharmaceuticals, Inc | 2 |
| Affimed GmbH | 1 |
| BeiGene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 34 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Immunoblastic Lymphadenopathy | 10 |
| Lymphoma, Large-Cell, Anaplastic | 10 |
| Lymphoma, T-Cell, Cutaneous | 10 |
| Recurrence | 10 |
| Hodgkin Disease | 9 |
| Lymphoma, Extranodal NK-T-Cell | 9 |
| Burkitt Lymphoma | 8 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.